Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Cardiol Therapeutics Inc.
CRDL ยท SEC Filings
website
18
Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advanc...
Price
1.03
Market Cap
125.16 M
Float
103.21 M
Country
CA
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about CRDL
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Cardiol Therapeutics Inc.
CRDL ยท SEC Filings
103.21 M
Float
1.03
Price
125.16 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
40-F
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
Mar 31, 2026
40-F
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
Mar 31, 2025
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 1, 2024
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 28, 2023
40-F/A
Form 40-F/A - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]: [Amend]
Apr 20, 2022
40-F
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
Mar 24, 2022
News
TYPE
HEADLINE
FILED AT
6-K
Cardiol Therapeutics Enters Into $75 Million Open Market Sale Agreement with Jefferies
Nov 3, 2026
6-K
Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC
Nov 3, 2026
6-K
Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial
Sep 23, 2026
6-K
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds and Extension of Cash Runway
Sep 16, 2026
6-K
Cardiol Therapeutics Inc. Code of Business Conduct and Ethics
Sep 14, 2026
6-K
Master Services Agreement between Cardiol Therapeutics and Dalton Pharma Services
Sep 10, 2026
Prospectus
TYPE
HEADLINE
FILED AT
Registrations
TYPE
HEADLINE
FILED AT
F-10/A
September 2026 SHELF
Sep 16, 2026
F-10
September 2026 SHELF
Sep 10, 2026
F-10
November 2025 SHELF
Nov 5, 2025
D
Form D - Notice of Exempt Offering of Securities - Item 06b
Nov 4, 2025
F-10/A
SHELF | Offering amount: $150,000,000.00 EFFECTIVE
Jul 12, 2024
F-10
SHELF | Offering amount: $150,000,000.00 EFFECTIVE
Jul 5, 2024
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G/A
Tejara Capital Ltd (Filed by)
Sep 23, 2026
SCHEDULE 13G/A
MMCAP International Inc. SPC (Filed by)
Aug 14, 2026
SCHEDULE 13G/A
MMCAP International Inc. SPC (Filed by)
May 15, 2026
SCHEDULE 13G
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jan 30, 2026
SCHEDULE 13G
Tejara Capital Ltd (Filed by)
Oct 23, 2025
SC 13G/A
MMCAP International Inc. SPC (Filed by)
Nov 6, 2024
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
SUPPL
Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
Nov 3, 2026
SUPPL
Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
Sep 16, 2026
SUPPL
Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
Nov 5, 2025
SUPPL
Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
Oct 9, 2024
SUPPL
Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
Oct 8, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Jul 17, 2024